Pulmonary Veno-occlusive Disease that Developed Following Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Intern Med. 2023 Jan 15;62(2):275-279. doi: 10.2169/internalmedicine.9811-22. Epub 2022 Jun 14.

Abstract

We herein report a case of pulmonary veno-occlusive disease (PVOD) induced by allo-hematopoietic stem cell transplantation (HSCT) in a 48-year-old man who was diagnosed with acute myeloid leukemia. Five months after transplantation, he developed dyspnea and was diagnosed with pulmonary hypertension based on right heart catheterization. Although he received treatment with pulmonary vasodilators, diuretics, and corticosteroids, his pulmonary artery pressure did not decrease, and his pulmonary edema worsened. Based on the clinical course, hypoxemia, diffusion impairment, and computed tomography findings, the patient was diagnosed with HSCT-related PVOD. Critical attention should be paid to dyspnea after HSCT for the early diagnosis of PVOD.

Keywords: acute myeloid leukemia (AML); hematopoietic stem cell transplantation (HSCT); pulmonary veno-occlusive disease (PVOD).

Publication types

  • Case Reports

MeSH terms

  • Dyspnea
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Lung
  • Male
  • Middle Aged
  • Pulmonary Veno-Occlusive Disease* / diagnostic imaging
  • Pulmonary Veno-Occlusive Disease* / etiology
  • Pulmonary Veno-Occlusive Disease* / therapy